Meiwu Technology shares surge 19.42% premarket after announcing strategic MOU with Real BioTech to expand beauty market presence via marine biotech collaboration.

Meiwu Technology surged 19.42% in premarket trading following the announcement of a non-binding Strategic Cooperation Memorandum of Understanding (MOU) with Real BioTech (Qingdao) Ltd. The partnership aims to combine Meiwu’s beauty industry platform with Real BioTech’s marine biotechnology expertise to develop natural, science-backed skincare solutions utilizing marine active ingredients. The collaboration is positioned to expand Meiwu’s market share in China and globally, aligning with growing consumer demand for efficacy-driven products. By integrating Real BioTech’s R&D capabilities and marine resources, the company emphasized enhanced innovation in a high-growth sector, reinforcing its long-term strategy. The MOU, disclosed on November 25, 2025, was highlighted as a catalyst for synergistic growth, directly supporting the stock’s sharp premarket rise.